Go AS - Search Results

1

Anemia and risk for cognitive decline in chronic kidney disease.

Kurella Tamura M, Vittinghoff E, Yang J, Go AS, Seliger SL, Kusek JW, Lash J, Cohen DL, Simon J, Batuman V, Ordonez J, Makos G, Yaffe K. Kurella Tamura M, et al. Among authors: go as. BMC Nephrol. 2016 Jan 28;17:13. doi: 10.1186/s12882-016-0226-6. BMC Nephrol. 2016. PMID: 26823182 Free PMC article.

2

Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.

Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Hsu CY, et al. Among authors: go as. Arch Intern Med. 2005 Apr 25;165(8):923-8. doi: 10.1001/archinte.165.8.923. Arch Intern Med. 2005. PMID: 15851645

3

Health-related quality of life and estimates of utility in chronic kidney disease.

Gorodetskaya I, Zenios S, McCulloch CE, Bostrom A, Hsu CY, Bindman AB, Go AS, Chertow GM. Gorodetskaya I, et al. Among authors: go as. Kidney Int. 2005 Dec;68(6):2801-8. doi: 10.1111/j.1523-1755.2005.00752.x. Kidney Int. 2005. PMID: 16316356 Free article.

4

Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease.

Go AS, Lo JC. Go AS, et al. Curr Opin Nephrol Hypertens. 2006 May;15(3):296-302. doi: 10.1097/01.mnh.0000222698.30207.aa. Curr Opin Nephrol Hypertens. 2006. PMID: 16609298 Review.

5

Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG. Go AS, et al. Circulation. 2006 Jun 13;113(23):2713-23. doi: 10.1161/CIRCULATIONAHA.105.577577. Epub 2006 Jun 5. Circulation. 2006. PMID: 16754803

6

Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease.

Peralta CA, Shlipak MG, Fan D, Ordoñez J, Lash JP, Chertow GM, Go AS. Peralta CA, et al. Among authors: go as. J Am Soc Nephrol. 2006 Oct;17(10):2892-9. doi: 10.1681/ASN.2005101122. Epub 2006 Sep 7. J Am Soc Nephrol. 2006. PMID: 16959827

7

Statin therapy and risks for death and hospitalization in chronic heart failure.

Go AS, Lee WY, Yang J, Lo JC, Gurwitz JH. Go AS, et al. JAMA. 2006 Nov 1;296(17):2105-11. doi: 10.1001/jama.296.17.2105. JAMA. 2006. PMID: 17077375

8

Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.

Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R. Go AS, et al. Am J Cardiol. 2007 Aug 15;100(4):690-6. doi: 10.1016/j.amjcard.2007.03.084. Epub 2007 Jun 26. Am J Cardiol. 2007. PMID: 17697830

9

GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD.

Lo JC, Go AS, Chandra M, Fan D, Kaysen GA. Lo JC, et al. Among authors: go as. Am J Kidney Dis. 2007 Oct;50(4):552-8. doi: 10.1053/j.ajkd.2007.07.011. Am J Kidney Dis. 2007. PMID: 17900454

10

Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice.

Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R. Go AS, et al. Arch Intern Med. 2008 Dec 8;168(22):2415-21. doi: 10.1001/archinternmed.2008.506. Arch Intern Med. 2008. PMID: 19064823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

656 results

Search Page